Chronic cough, defined as a cough lasting more than eight weeks, presents a common yet complex challenge in clinical practice. Despite its prevalence, the etiology often remains elusive, leading to diagnostic uncertainty and therapeutic dilemmas. This article aims to illuminate a comprehensive approach to diagnosing and managing chronic cough.
Chronic cough can be attributed to a myriad of causes, from common conditions like asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS) to less prevalent etiologies like lung cancer. A detailed patient history coupled with targeted investigations can help pinpoint the underlying cause.
The diagnostic approach should be systematic and patient-centric. Initial evaluation should include a thorough history and physical examination, focusing on identifying common causes and risk factors. If the cause is not readily apparent, further investigations such as imaging, spirometry, and bronchoscopy may be warranted. Empirical therapy can be considered in certain cases, but should not delay definitive diagnosis.
Management should be tailored based on the identified etiology. For instance, asthma-related cough may respond well to inhaled corticosteroids, while GERD-associated cough may require proton pump inhibitors. Non-pharmacological interventions, such as lifestyle modifications and physiotherapy, can also play a crucial role. Refractory cases may necessitate referral to a specialist.
Research is ongoing to develop novel diagnostic tools and therapeutic options for chronic cough. Emerging modalities like cough reflex testing and potential new drugs targeting neural pathways are promising. More studies are needed to validate their efficacy and safety.
Chronic cough is a multifaceted problem requiring a comprehensive and individualized approach. By maintaining a high index of suspicion, employing a systematic diagnostic strategy, and tailoring management based on etiology, clinicians can effectively diagnose and manage this common but often perplexing condition.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation